EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

FOXA1 mutations co-opt nascent transcription factor networks in partnership with androgen receptor to enhance prostate tumorigenicity

Erik M Ladewig, Abbas Nazir, Tyler Park, Vinson B Fan, Zhendong Cao, Jacob Hawk, Lauren Kelly, Robert Tjian, Christina S Leslie, Charles L Sawyers

Cell Reports · 2026

DOI: 10.1016/j.celrep.2026.116950 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Cell Reports, 2026. Verfasst von Erik M Ladewig und 9 weiteren Autor:innen. Beteiligte Einrichtung: Computational and Systems Biology Program, Memorial Sloan Kettering Cancer Center, New York, NY 10065, USA. Hauptthemen laut MEDLINE: Hepatocyte Nuclear Factor 3-alpha, Prostatic Neoplasms, Receptors, Androgen. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 50 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: NCI NIH HHS, National Institutes of Health, National Cancer Institute.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Mutations in the pioneer transcription factor FOXA1 occur in 10%-40% of prostate cancers and broadly alter chromatin accessibility. In a cohort of 874 primary and metastatic tumors, we confirm frequent Wing2 missense mutations and indels, as well as C-terminal truncating frameshifts. To define their functional impact, we performed single-nucleus multiome profiling in mouse prostate organoids expressing representative alleles, including overexpressed wild-type FOXA1. Each subgroup produces distinct chromatin and transcriptional changes, but all perturb epithelial lineage specification. Indel mutants promote basal-like states, whereas C-terminal truncations, Wing2 missense mutations, and elevated wild-type FOXA1 drive secretory L1-like luminal fates. Integrated RNA-seq, ATAC-seq, and ChIP-seq reveal that L1-like specification involves a hybrid androgen receptor/FOXA1 motif and cooperation with POU2F1. In vivo, these same alleles, combined with Trp53/Pten loss, shift tumor histology from basal-like to secretory luminal phenotypes.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Hepatocyte Nuclear Factor 3-alphaProstatic NeoplasmsReceptors, AndrogenCarcinogenesisINDEL MutationMutation, MissenseOctamer Transcription Factor-1Gene Expression Regulation, NeoplasticProstateTumor Suppressor Protein p53OrganoidsNeoplasms, ExperimentalHumansMaleAnimalsMicePrimary Cell CultureFrameshift MutationRNA-SeqCell Line, Tumor

Stichwörter der Autor:innen

CP: cancerCP: molecular biologyFOXA1POU2F1basalluminalprostate

Substanzen

FOXA1 protein, humanFoxa1 protein, mouseHepatocyte Nuclear Factor 3-alphaOctamer Transcription Factor-1Tumor Suppressor Protein p53Receptors, Androgen

Autor:innen und Institutionen

  • Computational and Systems Biology Program, Memorial Sloan Kettering Cancer Center, New York, NY 10065, USA.
  • Human Oncology and Pathogenesis Program, Memorial Sloan Kettering Cancer Center, New York, NY 10065, USA.
  • Department of Molecular & Cell Biology, University of California Berkeley, Berkeley, CA 94720, USA.
  • Computational and Systems Biology Program, Memorial Sloan Kettering Cancer Center, New York, NY 10065, USA. Electronic address: lesliec@mskcc.org.
  • Human Oncology and Pathogenesis Program, Memorial Sloan Kettering Cancer Center, New York, NY 10065, USA. Electronic address: sawyersc@mskcc.org.

Förderung

  • NCI NIH HHS
  • National Institutes of Health
  • National Cancer Institute
  • Calico Life Sciences
  • Howard Hughes Medical Institute
  • National Cancer Institute Division of Cancer Prevention

Zitieren

APA

Ladewig, E. M., Nazir, A., Park, T., Fan, V. B., Cao, Z., Hawk, J., Kelly, L., Tjian, R., Leslie, C. S., & Sawyers, C. L. (2026). FOXA1 mutations co-opt nascent transcription factor networks in partnership with androgen receptor to enhance prostate tumorigenicity. Cell Reports. https://doi.org/10.1016/j.celrep.2026.116950

Vancouver

Ladewig EM, Nazir A, Park T, Fan VB, Cao Z, Hawk J, et al. FOXA1 mutations co-opt nascent transcription factor networks in partnership with androgen receptor to enhance prostate tumorigenicity. Cell Reports. 2026. doi:10.1016/j.celrep.2026.116950

BibTeX
@article{Ladewig2026,
  author = {Ladewig, Erik M and Nazir, Abbas and Park, Tyler and Fan, Vinson B and Cao, Zhendong and Hawk, Jacob and Kelly, Lauren and Tjian, Robert and Leslie, Christina S and Sawyers, Charles L},
  title = {FOXA1 mutations co-opt nascent transcription factor networks in partnership with androgen receptor to enhance prostate tumorigenicity},
  journal = {Cell Reports},
  year = {2026},
  doi = {10.1016/j.celrep.2026.116950}
}
Kostenlos starten →